Yapan Bio
Tracked across 5 events · 61 articles · First seen Apr 28, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Target; became a subsidiary of Piramal Pharma, gaining access to broader resources and integration into PPL's global network.
Jul 20, 2026 · 11 articles
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in the biologics/bio-therapeutics and vaccine segments.
Apr 28, 2026 · 14 articles
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in biologics and vaccines.
Jul 07, 2026 · 14 articles
Business
Impact: Associate company of Piramal Pharma; not directly involved in this expansion.
Aug 04, 2026 · 12 articles
Business
Impact: Piramal Group has a strategic minority investment in Yapan Bio, which operates in biologics and vaccine segments.
Jul 29, 2026 · 10 articles
ERGEN INTELLIGENCE
Track Yapan Bio live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard